Peptides News and Research

RSS

ImmusanT receives JDRF T1D Fund to develop novel vaccine candidate for type 1 diabetes

ImmusanT, Inc., a clinical stage company that is leveraging its Epitope-Specific Immuno-Therapy™ platform to translate and deliver first-in-class peptide-based immune therapies to people living with autoimmune diseases, today announced that it has received an investment from the JDRF T1D Fund, a venture philanthropy fund exclusively devoted to finding and funding the best type 1 diabetes commercial opportunities.

11 Sep 2018

Immune system that fights infection could join battle against opioid addiction

The same immune system that fights infection and the flu could join the battle against opioid addiction, new research out of the Vanderbilt Center for Addiction Research indicates.

7 Sep 2018

Researchers synthesize new antibacterial polymers without hydrophobic alkyl chains

Artificial polymers, like antibiotic peptides, need both hydrophobic and hydrophilic domains in their molecular structure to exert antibacterial activity.

7 Sep 2018

Immune system may join battle against opioid addiction

The same immune system that fights infection and the flu could join the battle against opioid addiction, new research out of the Vanderbilt Center for Addiction Research indicates.

6 Sep 2018

Simulations provide better understanding of calcium's role in titanium implant acceptance

Titanium-based materials are widely used in medical implant technology. Coating the surface of titanium materials with biologically active molecules has recently shown promise to improve how cells adhere to implants and promote tissue regeneration. The mechanisms behind how peptides stick to titanium, however, are not fully understood.

5 Sep 2018

Soluble versions of immune cell protein could help treat Alzheimer's disease, study reveals

Researchers at the University of Florida have discovered that a modified version of an important immune cell protein could be used to treat Alzheimer's disease.

29 Aug 2018

Biochemist's startup secures license for developing technology that could treat PTSD

A biochemist's startup company announced Monday that it had secured an exclusive patent license agreement with the Air Force Research Laboratory for a breakthrough technology that could help military veterans suffering from a post-traumatic stress disorder.

28 Aug 2018

Peptilogics held pre-IND meeting with FDA to develop PLG0206 for treating prosthetic joint infections

Peptilogics, a development stage company utilizing its innovative peptide platform to treat multidrug-resistant bacterial infections, today announced it recently held a pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration to discuss the regulatory pathway for the development of PLG0206 for the treatment of prosthetic joint infections.

25 Aug 2018

Scientists design biomaterial that stimulates growth of blood vessels in teeth after root canal

A root canal ranks high on most people's list of dreaded dental procedures. Although the lengthy and sometimes painful surgery relieves the agony of an infection, a root canal results in a dead tooth with no living soft tissue, or dental pulp, inside.

22 Aug 2018

Researchers engineer peptide nanoparticles to outsmart biological system and target kidney cells

Remember the scene in the movie Mission: Impossible when Tom Cruise has to sneak into the vault? He had to do all sorts of moves to avoid detection. That's what it's like to sneak a targeted drug into a kidney and keep it from getting eliminated from the body.

22 Aug 2018

Scientists discover peptides that can be used as new antibiotic candidates

The human body produces many antimicrobial peptides that help the immune system fend off infection. Scientists hoping to harness these peptides as potential antibiotics have now discovered that other peptides in the human body can also have potent antimicrobial effects, expanding the pool of new antibiotic candidates.

21 Aug 2018

New tool fills gap in Small Molecules market

This news story covers the launch of SmallMolecules.com, an online tool for scientists looking to buy and compare molecules for their experiments.

From SmallMolecules.com 17 Aug 2018

Discovery may help broaden the scope of defenses against HPV

Yale Cancer Center scientists have filled in a key gap in understanding the unusual route by which the Human papillomavirus infects cells.

16 Aug 2018

Researchers identify way to grow immune cells at large scale for preventing cancer reoccurrence

For the first time, Mount Sinai researchers have identified a way to make large numbers of immune cells that can help prevent cancer reoccurrence, according to a study published in August in Cell Reports.

15 Aug 2018

Finding the light in antimicrobials

Hundreds of polymers which kill drug-resistant superbugs in novel ways could be produced and tested using light, using this new method.

14 Aug 2018

Simple score helps predict which hospitalized heart attack patients are at high risk of readmissions

Tracking just seven factors of heart attack patients when they are first admitted to the hospital can help flag those most at risk for 30-day readmission, researchers from UT Southwestern found.

13 Aug 2018

Discovery could lead to new drugs against infection and inflammation

Researchers at Lund University in Sweden, have in collaboration with colleagues in Copenhagen and Singapore, mapped how the body's own peptides act to reduce infection and inflammation by deactivating the toxic substances formed in the process.

13 Aug 2018

MSU researchers uncover the effects of aging on regenerative ability of kidneys

Autophagy is a process of destruction and processing of damaged cell components by the cells themselves. It is used by a cell to clean itself of excessive organelles and sometimes for self-execution. This adaptive mechanism supports a healthy phenotype on the cellular level.

13 Aug 2018

Collaboration between Merck and InnoCore could improve biologic drug delivery

Following today’s (Friday 3 August) announcement of Merck and InnoCore’s collaboration, Rahael Maladwala, Pharma Analyst at GlobalData, a leading data and analytics company, offers his view on what this might mean for biologic drug delivery:

10 Aug 2018

Researchers describe new class of potent inhibitors against amyloid plaques

Effective therapeutics to counteract the formation of amyloid plaques in Alzheimer's disease and type 2 diabetes are not yet available.

9 Aug 2018

Peptides News and Research

ImmusanT receives JDRF T1D Fund to develop novel vaccine candidate for type 1 diabetes

Immune system that fights infection could join battle against opioid addiction

Researchers synthesize new antibacterial polymers without hydrophobic alkyl chains

Immune system may join battle against opioid addiction

Simulations provide better understanding of calcium's role in titanium implant acceptance

Soluble versions of immune cell protein could help treat Alzheimer's disease, study reveals

Biochemist's startup secures license for developing technology that could treat PTSD

Peptilogics held pre-IND meeting with FDA to develop PLG0206 for treating prosthetic joint infections

Scientists design biomaterial that stimulates growth of blood vessels in teeth after root canal

Researchers engineer peptide nanoparticles to outsmart biological system and target kidney cells

Scientists discover peptides that can be used as new antibiotic candidates

New tool fills gap in Small Molecules market

Discovery may help broaden the scope of defenses against HPV

Researchers identify way to grow immune cells at large scale for preventing cancer reoccurrence

Finding the light in antimicrobials

Simple score helps predict which hospitalized heart attack patients are at high risk of readmissions

Discovery could lead to new drugs against infection and inflammation

MSU researchers uncover the effects of aging on regenerative ability of kidneys

Collaboration between Merck and InnoCore could improve biologic drug delivery

Researchers describe new class of potent inhibitors against amyloid plaques

Editorial Focus eBook - Peptides and Oligonucleotides (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News